PineBridge Investments, L.P. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 199 filers reported holding NEKTAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
PineBridge Investments, L.P. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2019$10,000
-64.3%
283
-65.9%
0.00%
-100.0%
Q1 2019$28,000
-91.5%
830
-91.8%
0.00%
-85.7%
Q4 2018$331,000
-47.7%
10,074
-3.1%
0.01%
-41.7%
Q3 2018$633,000
+3416.7%
10,394
+2664.4%
0.01%
Q2 2018$18,000
-70.0%
376
-32.6%
0.00%
-100.0%
Q1 2018$60,000
-99.2%
558
-99.6%
0.00%
-99.5%
Q4 2017$7,739,000
+246.4%
129,592
+39.3%
0.20%
+268.5%
Q3 2017$2,234,000
+21.9%
93,064
-0.7%
0.05%
+12.5%
Q2 2017$1,832,000
+289.0%
93,694
+366.9%
0.05%
+300.0%
Q1 2017$471,000
+93.8%
20,066
+1.2%
0.01%
+71.4%
Q4 2016$243,000
-18.7%
19,827
+14.0%
0.01%
-46.2%
Q3 2016$299,000
+21.5%
17,385
+0.6%
0.01%0.0%
Q2 2016$246,000
+7.9%
17,281
+4.0%
0.01%
+8.3%
Q1 2016$228,000
-24.3%
16,610
-7.3%
0.01%
-7.7%
Q4 2015$301,000
+63.6%
17,912
+7.0%
0.01%
+62.5%
Q3 2015$184,000
-3.2%
16,743
+10.4%
0.01%0.0%
Q2 2015$190,00015,1660.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2016
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 1,350,000$22,950,0001.87%
MAVERICK CAPITAL LTD 6,655,625$113,146,0001.81%
Camber Capital Management LP 2,500,000$42,500,0001.49%
Bellevue Group AG 3,866,258$65,726,0000.75%
Adero Partners, LLC 51,500$876,0000.75%
Goodman Financial Corp 108,342$1,842,0000.64%
CM Management, LLC 35,000$595,0000.55%
OSTERWEIS CAPITAL MANAGEMENT INC 424,504$7,217,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 568,379$9,662,0000.34%
Burleson & Company, LLC 107,736$1,832,0000.32%
View complete list of NEKTAR THERAPEUTICS shareholders